Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy

…, F Magri, G Menozzi, C Bonaglia, F Rizzo… - Science translational …, 2012 - science.org
Spinal muscular atrophy (SMA) is among the most common genetic neurological diseases
that cause infant mortality. Induced pluripotent stem cells (iPSCs) generated from skin …

[HTML][HTML] Direct reprogramming of human astrocytes into neural stem cells and neurons

…, M Falcone, C Donadoni, S Salani, F Rizzo… - Experimental cell …, 2012 - Elsevier
Generating neural stem cells and neurons from reprogrammed human astrocytes is a
potential strategy for neurological repair. Here we show dedifferentiation of human cortical …

Neural stem cell transplantation for neurodegenerative diseases

R De Gioia, F Biella, G Citterio, F Rizzo, E Abati… - International journal of …, 2020 - mdpi.com
Neurodegenerative diseases are disabling and fatal neurological disorders that currently lack
effective treatment. Neural stem cell (NSC) transplantation has been studied as a potential …

MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives

G Stuppia, F Rizzo, G Riboldi, R Del Bo… - Journal of the …, 2015 - Elsevier
Mitofusin 2 (MFN2) is a GTPase dynamin-like protein of the outer mitochondrial membrane,
encoded in the nuclear genome by the MFN2 gene located on the short (p) arm of …

Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis …

M Nizzardo, C Simone, F Rizzo… - Human molecular …, 2014 - academic.oup.com
Amyotrophic lateral sclerosis (ALS) is a fatal neurological disease characterized by the
degeneration of motor neurons. Currently, there is no effective therapy for ALS. Stem cell …

[HTML][HTML] Mitochondrial fusion proteins and human diseases

…, S Brajkovic, G Riboldi, D Ronchi, F Rizzo… - Neurology research …, 2013 - hindawi.com
Mitochondria are highly dynamic, complex organelles that continuously alter their shape,
ranging between two opposite processes, fission and fusion, in response to several stimuli and …

Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis

F Rizzo, G Riboldi, S Salani, M Nizzardo… - Cellular and Molecular …, 2014 - Springer
Neurodegenerative disorders are characterized by the selective vulnerability and progressive
loss of discrete neuronal populations. Non-neuronal cells appear to significantly contribute …

Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies

S Salani, C Donadoni, F Rizzo… - Journal of cellular …, 2012 - Wiley Online Library
• Introduction • Transdifferentiation of somatic cells in skeletal myoblasts • Myogenic cell
induction from ESCs ‐ The first method: generation of MMPs from ESCs and their differentiation …

Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neurons

F Rizzo, D Ronchi, S Salani, M Nizzardo… - Human molecular …, 2016 - academic.oup.com
Charcot-Marie-Tooth 2A (CMT2A) is an inherited peripheral neuropathy caused by mutations
in MFN2, which encodes a mitochondrial membrane protein involved in mitochondrial …

Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model

M Nizzardo, C Simone, F Rizzo, S Salani, S Dametti… - Science …, 2015 - science.org
Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is an autosomal recessive
motor neuron disease affecting children. It is caused by mutations in the IGHMBP2 gene (…